|
Name |
Prenylcandidusin C
|
Molecular Formula | C26H26O6 | |
IUPAC Name* |
7-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-3,6,9-trimethoxydibenzofuran-2-ol
|
|
SMILES |
CC(=CCC1=C(C=CC(=C1)C2=CC(=C3C4=CC(=C(C=C4OC3=C2OC)OC)O)OC)O)C
|
|
InChI |
InChI=1S/C26H26O6/c1-14(2)6-7-16-10-15(8-9-19(16)27)17-12-23(30-4)24-18-11-20(28)22(29-3)13-21(18)32-26(24)25(17)31-5/h6,8-13,27-28H,7H2,1-5H3
|
|
InChIKey |
HWBQSNYBSJLMIS-UHFFFAOYSA-N
|
|
Synonyms |
Prenylcandidusin C; CHEBI:67532; CHEMBL1795463; DTXSID301315811; Q27136001; 7-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-3,6,9-trimethoxydibenzo[b,d]furan-2-ol; 1297472-20-8
|
|
CAS | 1297472-20-8 | |
PubChem CID | 53354807 | |
ChEMBL ID | CHEMBL1795463 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 434.5 | ALogp: | 6.4 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 81.3 | Aromatic Rings: | 4 |
Heavy Atoms: | 32 | QED Weighted: | 0.351 |
Caco-2 Permeability: | -5.001 | MDCK Permeability: | 0.00001550 |
Pgp-inhibitor: | 0.701 | Pgp-substrate: | 0.025 |
Human Intestinal Absorption (HIA): | 0.027 | 20% Bioavailability (F20%): | 0.007 |
30% Bioavailability (F30%): | 0.03 |
Blood-Brain-Barrier Penetration (BBB): | 0.002 | Plasma Protein Binding (PPB): | 84.17% |
Volume Distribution (VD): | 0.527 | Fu: | 20.03% |
CYP1A2-inhibitor: | 0.725 | CYP1A2-substrate: | 0.931 |
CYP2C19-inhibitor: | 0.919 | CYP2C19-substrate: | 0.096 |
CYP2C9-inhibitor: | 0.845 | CYP2C9-substrate: | 0.918 |
CYP2D6-inhibitor: | 0.209 | CYP2D6-substrate: | 0.925 |
CYP3A4-inhibitor: | 0.29 | CYP3A4-substrate: | 0.315 |
Clearance (CL): | 11.372 | Half-life (T1/2): | 0.427 |
hERG Blockers: | 0.028 | Human Hepatotoxicity (H-HT): | 0.705 |
Drug-inuced Liver Injury (DILI): | 0.949 | AMES Toxicity: | 0.473 |
Rat Oral Acute Toxicity: | 0.107 | Maximum Recommended Daily Dose: | 0.838 |
Skin Sensitization: | 0.674 | Carcinogencity: | 0.102 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.687 |
Respiratory Toxicity: | 0.608 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002760 | 0.847 | D06GCK | 0.450 | ||||
ENC005879 | 0.727 | D0Q0PR | 0.333 | ||||
ENC002471 | 0.624 | D0Y7TS | 0.323 | ||||
ENC005880 | 0.585 | D0NJ3V | 0.311 | ||||
ENC002758 | 0.582 | D09DHY | 0.310 | ||||
ENC005867 | 0.577 | D02LZB | 0.302 | ||||
ENC002475 | 0.573 | D04AIT | 0.301 | ||||
ENC002853 | 0.553 | D0A8FB | 0.295 | ||||
ENC002776 | 0.550 | D0K8KX | 0.284 | ||||
ENC005868 | 0.549 | D0V8HJ | 0.284 |